Your browser doesn't support javascript.
loading
[Critical quality attribute characterization of big brand TCM: taste formulation optimization strategy and application of Xiaoer Ganmao Oral Liquid based on taste quality attribute].
Lu, Ying; Zeng, Jing-Qi; Ma, Jin-Chen; Dai, Xing-Xing; Zhu, Jin-Yuan; Zhang, Fang-Yu; Zhu, Ming-Li; Zhang, Han; Yao, Lu; Wang, Shu-Ying; Zuo, Yan; Wu, Zhi-Sheng.
Afiliação
  • Lu Y; School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China Engineering Research Center of Chinese Medicine Production and New Drug Development, Ministry of Education of People's Republic of China Beijing 102488, China.
  • Zeng JQ; School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China Engineering Research Center of Chinese Medicine Production and New Drug Development, Ministry of Education of People's Republic of China Beijing 102488, China.
  • Ma JC; School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China Engineering Research Center of Chinese Medicine Production and New Drug Development, Ministry of Education of People's Republic of China Beijing 102488, China.
  • Dai XX; School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China Engineering Research Center of Chinese Medicine Production and New Drug Development, Ministry of Education of People's Republic of China Beijing 102488, China.
  • Zhu JY; School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China Engineering Research Center of Chinese Medicine Production and New Drug Development, Ministry of Education of People's Republic of China Beijing 102488, China.
  • Zhang FY; School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China Engineering Research Center of Chinese Medicine Production and New Drug Development, Ministry of Education of People's Republic of China Beijing 102488, China.
  • Zhu ML; School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China Engineering Research Center of Chinese Medicine Production and New Drug Development, Ministry of Education of People's Republic of China Beijing 102488, China.
  • Zhang H; School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China Engineering Research Center of Chinese Medicine Production and New Drug Development, Ministry of Education of People's Republic of China Beijing 102488, China.
  • Yao L; National Engineering Research Center for R&D of Traditional Chinese Medicine Multi-ingredient Drugs Beijing 100079, China.
  • Wang SY; National Engineering Research Center for R&D of Traditional Chinese Medicine Multi-ingredient Drugs Beijing 100079, China.
  • Zuo Y; Pharmaceutical Factory, Beijing Tongrentang Science and Technology Co., Ltd. Beijing 100079, China.
  • Wu ZS; School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China Engineering Research Center of Chinese Medicine Production and New Drug Development, Ministry of Education of People's Republic of China Beijing 102488, China.
Zhongguo Zhong Yao Za Zhi ; 47(13): 3488-3494, 2022 Jul.
Article em Zh | MEDLINE | ID: mdl-35850800
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paladar / Nariz Eletrônico Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Assunto da revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paladar / Nariz Eletrônico Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Assunto da revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China